CCL2 and dementia: Increased inflammatory markers such as soluble tumor necrosis factor receptor 2 (sTNFR2), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) have been reported in patients with dementia compared with controls (9, 10).